This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Burnier, M. Search for Related Content PubMed PubMed Citation Articles by Burnier, M. Social Bookmarking                         What's this?

Blockade of the renin-angiotensin system for renal future perspectives protection: from history to future perspective

Division of Nephrology and Hypertension Lausanne, Switzerland

References

• Kobori H., Nangaku M., Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007;59:251-87.[Abstract/Free Full Text]
• Hostetter TH, Rennke H., Brenner BM The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982;72:375-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Brunner HR, Kirsman DJ, Sealey JE, Laragh JH Hypertension of renal origin: evidence for two different mechanisms. Science 1971;174:1344-6.[Abstract/Free Full Text]
• Gavras H., Brunner HR, Vaughan ED Jr, Laragh JH Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats. Science 1973;180:1369-72.[Abstract/Free Full Text]
• Brunner HR, Gavras H., Laragh JH, Keenan R. Ang II blockade in man by Sar1-Ala8-angiotensin II for understanding and treatment of high blood pressure. Lancet 1973;2:1045-8.[Web of Science][Medline] [Order article via Infotrieve]
• Gavras H., Ribeiro AB, Gavras I., Brunner HR Reciprocal relation between renin dependency and sodium dependency in essential hypertension. N Engl J Med 1976;295:1278-83.[Abstract]
• Ferguson RK, Turini GA, Brunner HR, Gavras H., McKinstry D. A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet 1977;1:775-8.[Web of Science][Medline] [Order article via Infotrieve]
• Brunner HR, Waeber B., Wauters JP et al. Inappropriate renin secretion in hypertension of chronic renal failure unmasked by captopril (SQ 14,225). Lancet 1978;2:704-07.[Web of Science][Medline] [Order article via Infotrieve]
• Lazarus JM, Hampers CL, Bennett AH et al. Urgent bilateral nephrectomy for severe hypertension. Ann Intern Med 1972;76:733.[Abstract/Free Full Text]
• Hollenberg NK, Williams GH, Taub KJ et al. Renal vascular response to interruption of the renin-angiotensin system in normal man. Kidney Int 1977;12:285-93.[Web of Science][Medline] [Order article via Infotrieve]
• Burnier M., Rutschmann B., Nussberger J. et al. Salt-dependent renal effects of angiotensin II antagonist in healthy subjects. Hypertension 1993;22:339-47.[Abstract/Free Full Text]
• Gansevoort RT, deZeeuw D., De Jong PE Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin angiotensin system? Kidney Int 1994;45:861-7.[Web of Science][Medline] [Order article via Infotrieve]
• Anderson S., Rennke HG, Brenner BM Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.[Web of Science][Medline] [Order article via Infotrieve]
• Zatz R., Rentz Dunn B., Meyer TW et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-30.[Web of Science][Medline] [Order article via Infotrieve]
• Taguma Y., Kitamoto Y., Futaki G. et al. Effect of captopril on heavy proteinuria in azometic diabetics. N Eng J Med 1985;313:1617-20.[Abstract]
• Ravid M., Lang R., Rachmani R., Lishner M. Long-term renal protective effect of angiotensin converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Int Med 1996;156:286-9.[Abstract/Free Full Text]
• Gansevoort RT, Sluiter WA, Hemmelder MH et al. Antiproteinuric effect of blood pressure lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 1995;10:1963-74.[Abstract/Free Full Text]
• Lewis EJ, Hunsicker LG, Bain RP, Rohde RD The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-62.[Abstract/Free Full Text]
• Holman R., Turner R., Stratton I. et al. for the UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-20.[Abstract/Free Full Text]
• Maschio G., Alberti D., Janin G. et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996;334:939-45.[Abstract/Free Full Text]
• Burnier M. Angiotensin II type 1 receptor blockers. Circulation 2001;103:904-12.[Free Full Text]
• Brenner BM, Cooper ME, de Zeeuw D. et al. RENAAL Study Investigators. Effects of losartan on renal and cardio-vascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.[Abstract/Free Full Text]
• Lewis EJ, Hunsicker, LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.[Abstract/Free Full Text]
• Parving HH, Lehnert H., Brochner-Mortensen J. et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-8.[Abstract/Free Full Text]
• Viberti G., Wheeldon NM MicroAlbuminuria Reduction With VALsartan (MARVAL) study Investigators. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation 2002;106:672-8.[Abstract/Free Full Text]
• Mogensen CE, Neldam S., Tikkanen I. et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000;321:1440-4.[Abstract/Free Full Text]
• Burgess E., Bakris G., Weir M., Koval S. Comparative long term effects of two AT1 receptor blockers on proteinuria in patients with type 2 diabetes and overt nephropathy and hypertension: results of the AMADEO trial. J Hypertens 2007;25:S276.
• Barnett AH, Bain SC, Bouter P., Karlberg B., Madsbad S., Jervell J., Mustonen J. Angiotensin-receptor blockade versus converting enzyme inhibition in type 2 diabetes and nephropathy. N Eng J Med 2004;351:1952-61.[Abstract/Free Full Text]
• Ruggenenti P., Fassi A., Ilieva AP et al. Preventing microalbuminuria in type 2 diabetes. N Eng J Med 2004;351:1941-51.[Abstract/Free Full Text]
• Mancia G., De Backer G., Dominiczak A. et al. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007;25:1105-87.
• Azizi M., Chatellier G., Guyene TT, Murieta-Geoffroy D., Ménard J. Additive effects of combined angiotensinconverting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodiumdepleted normotensives. Circulation 1995;92:825-34.[Abstract/Free Full Text]
• Nakao N., Yoshimura A., Morita H. et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003;361:117-24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kunz R., Friedrich C., Wolbers M., Mann J FE Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease. Ann Intern Med 2007, epub ahead of print.
• Parving HE, Lewis JB, Lewis EJ, Hollenberg NK Aliskiren in the evaluation of proteinuria in diabetes (AVOID). JASN SA-PO1051, 2007. (Abstract)
• Mazzolai L., Maillard M., Rossat J., Nussberger J., Brunner HR, Burnier M. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Hypertension 1999;33:850-5.[Abstract/Free Full Text]
• Forclaz A., Maillard M., Nussberger J., Brunner HR, Burnier M. Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor? Hypertension 2003;41:31-6.[Abstract/Free Full Text]
• Rossing K., Schjoedt KJ, Jensen BR, Boomsma, Parving HH Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 2005;68:1190-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schmieder RE, Klingbeil AU, Fleischmann EH, Veelken R., Delles C. Additional antiproteinuric effect of ultrahigh dose of candesartan: a double-blind, randomized prospective study. JASN 2005;16:3038-45.[Abstract/Free Full Text]
• Hollenberg NK, Parving HH, Viberti G. et al. Albuminuria response to very high dose of valsartan in type 2 diabetes mellitus. J Hypertens 2007;25:1921-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Burgess ED, Muirhead N., De Cotret PR A Double-Blind Randomized Controlled Trial of High Dose Candesartan Cilexetil in Proteinuric Renal Disease - Results from SMART (Supra Maximal Atacand Renal Trial). JASN SA-FC104, 2007. (Abstract)
• Bakris GL, Ruilope L., Locatelli F. et al. Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int 2007;72:879-85.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 4, 208-211 (2007)
DOI: 10.1177/14703203070080040102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Burnier, M. Search for Related Content PubMed PubMed Citation Articles by Burnier, M. Social Bookmarking                         What's this?